The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 2021

Filed:

Apr. 10, 2018
Applicant:

Alkermes, Inc., Waltham, MA (US);

Inventors:

Juan Alvarez, Lincoln, MA (US);

Demetri T. Moustakas, Belmont, MA (US);

Heather R. Brodkin, Warwick, RI (US);

Leslie A. McSweeney, Milford, MA (US);

Assignee:

Alkermes, Inc., Waltham, MA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/54 (2006.01); C07K 14/715 (2006.01); A61K 38/20 (2006.01); A61K 47/64 (2017.01); A61K 47/68 (2017.01); A61P 17/06 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01); A61K 38/17 (2006.01); A61K 38/21 (2006.01); A61K 38/48 (2006.01); C07K 14/55 (2006.01); C07K 14/565 (2006.01); C07K 14/705 (2006.01); C12N 9/64 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 38/179 (2013.01); A61K 38/1793 (2013.01); A61K 38/2013 (2013.01); A61K 38/2066 (2013.01); A61K 38/215 (2013.01); A61K 38/4846 (2013.01); C07K 14/5428 (2013.01); C07K 14/55 (2013.01); C07K 14/565 (2013.01); C07K 14/70578 (2013.01); C07K 14/7151 (2013.01); C07K 14/7155 (2013.01); C12N 9/644 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/70 (2013.01); C12Y 304/21022 (2013.01);
Abstract

The present invention provides novel, single chain Fc fusion proteins having improved properties. The invention provides single chain fusions of soluble proteins fused to the Fc region of an immunoglobulin via a novel linker comprising a constant region of an immunoglobulin light chain linked to a CH1 constant region of an immunoglobulin heavy chain. This novel linker confers favorable properties on the Fc fusion proteins of the invention such as improved bioactivity and increased half-life as compared to non-Fc fusion counterparts or as compared to prior art Fc fusion proteins. The novel Fc fusion protein scaffold as described herein may be designed to include soluble proteins of interest capable of binding or interacting with any target of interest. Preferably, the Fc fusion protein of the invention is a dimer. The dimer preferably forms via a disulfide bond between free cysteine residues in the hinge region of two monomeric Fc fusion proteins of the invention.


Find Patent Forward Citations

Loading…